Aura Biosciences (AURA) Non Operating Income (2021 - 2026)

Aura Biosciences (AURA) has 6 years of Non Operating Income data on file, last reported at $1.2 million in Q1 2026.

• Quarterly Non Operating Income fell 24.08% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.3 million (down 23.05% YoY) and the FY2025 annual result came in at $6.7 million, down 27.94% from the prior year.
• Non Operating Income declined to $1.2 million in Q1 2026, from $1.7 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $2.8 million in Q4 2023 to a low of -$24000.0 in Q1 2022.
• A 5-year average of $1.6 million and a median of $1.8 million in 2025 frame the typical range for Non Operating Income.
• Annual changes were most pronounced in 2022 — Non Operating Income surged 15157.14% — and 2025, when it tumbled 40.82%.
• Tracing AURA's Non Operating Income over 5 years: stood at $1.1 million in 2022, then jumped by 164.61% to $2.8 million in 2023, then fell by 28.4% to $2.0 million in 2024, then slipped by 15.22% to $1.7 million in 2025, then fell by 29.59% to $1.2 million in 2026.
• The last three Non Operating Income figures came in at $1.2 million (Q1 2026), $1.7 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.